Wave Life Sciences Ltd.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
54.06 |
51.95 |
55.06 |
130.49 |
216.95 |
328.78 |
| Przychód Δ r/r |
0.00% |
-3.92% |
5.99% |
136.98% |
66.26% |
51.55% |
| Przychód (min) |
27.43 |
23.80 |
23.20 |
126.23 |
91.42 |
138.54 |
| Przychód (max) |
98.79 |
68.74 |
81.78 |
134.74 |
322.22 |
488.32 |
| EBITDA (średnia) |
-48.21 |
-46.32 |
-49.10 |
-116.35 |
-193.44 |
-293.16 |
| EBIT (średnia) |
-49.74 |
-47.79 |
-50.66 |
-120.05 |
-199.60 |
-302.48 |
| EBIT % |
-92.00% |
-92.00% |
-92.00% |
-92.00% |
-92.00% |
-92.00% |
| Zysk netto (średni) |
-153.78 |
-157.91 |
-207.69 |
-150.97 |
-93.57 |
-55.54 |
| Zysk netto % |
-284.44% |
-303.97% |
-377.20% |
-115.70% |
-43.13% |
-16.89% |
| EPS (średnia) |
-1.14 |
-1.14 |
-1.17 |
-0.94 |
-0.68 |
-0.40 |
| Liczba analityków (Przychody) |
8 |
9 |
13 |
11 |
4 |
5 |
| Liczba analityków (EPS) |
8 |
8 |
12 |
11 |
5 |
4 |
| symbol |
WVE |
WVE |
WVE |
WVE |
WVE |
WVE |